Jonathan Baker

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Alasdair Munro, Shuo Feng, Leila Janani et al. · The Lancet Infectious Diseases · 2022 · 177 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Copper Stress Induces a Global Stress Response in <i>Staphylococcus aureus</i> and Represses <i>sae</i> and <i>agr</i> Expression and Biofilm Formation

Jonathan Baker, Sutthirat Sitthisak, Mrittika Sengupta et al. · Applied and Environmental Microbiology · 2009 · 162 citations

Life Sciences, Microbiology, Molecular Biology +17

The Rnf Complex Is an Energy-Coupled Transhydrogenase Essential To Reversibly Link Cellular NADH and Ferredoxin Pools in the Acetogen Acetobacterium woodii

Lars Westphal, Anja Wiechmann, Jonathan Baker et al. · Journal of Bacteriology · 2018 · 125 citations · Full text

Life Sciences, Biology, Microbiology +17

Sequence variations in the public human genome data reflect a bottlenecked population history

Gábor Marth, Greg Schuler, Raymond T. Yeh et al. · Proceedings of the National Academy of Sciences · 2002 · 120 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff et al. · The Lancet Infectious Diseases · 2022 · 88 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +14